Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Cost Analysis of Certolizumab Pegol Compared With Available Biologic Agents For Crohn's Disease In Mexico And Brazil.

Aguirre A, Naranjo M, Bierschwale H, Treglia M.

Value Health. 2015 Nov;18(7):A866. doi: 10.1016/j.jval.2015.09.521. Epub 2015 Oct 20. No abstract available.

2.

Integrating Multiple Distribution Models to Guide Conservation Efforts of an Endangered Toad.

Treglia ML, Fisher RN, Fitzgerald LA.

PLoS One. 2015 Jun 30;10(6):e0131628. doi: 10.1371/journal.pone.0131628. eCollection 2015.

3.

Species distribution modelling for conservation of an endangered endemic orchid.

Wang HH, Wonkka CL, Treglia ML, Grant WE, Smeins FE, Rogers WE.

AoB Plants. 2015 Apr 21;7. pii: plv039. doi: 10.1093/aobpla/plv039.

4.

Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus.

Ascher-Svanum H, Lage MJ, Perez-Nieves M, Reaney MD, Lorraine J, Rodriguez A, Treglia M.

Diabetes Ther. 2014 Jun;5(1):225-42. doi: 10.1007/s13300-014-0065-z. Epub 2014 Apr 30.

5.

The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.

Colazingari S, Treglia M, Najjar R, Bevilacqua A.

Arch Gynecol Obstet. 2013 Dec;288(6):1405-11. doi: 10.1007/s00404-013-2855-3. Epub 2013 May 25.

PMID:
23708322
6.

Monocytes from depressed patients display an altered pattern of response to endotoxin challenge.

Lisi L, Camardese G, Treglia M, Tringali G, Carrozza C, Janiri L, Dello Russo C, Navarra P.

PLoS One. 2013;8(1):e52585. doi: 10.1371/journal.pone.0052585. Epub 2013 Jan 3.

7.
8.

Road to the nursing home: costs and disease progression among medicare beneficiaries with ADRD.

Bentkover J, Cai S, Makineni R, Mucha L, Treglia M, Mor V.

Am J Alzheimers Dis Other Demen. 2012 Mar;27(2):90-9. doi: 10.1177/1533317512440494.

PMID:
22495336
9.

Development of a next day functioning measure to assess the impact of sleep disturbance due to restless legs syndrome: the restless legs syndrome-next day impact questionnaire.

Lasch KE, Abraham L, Patrick J, Piault EC, Tully SE, Treglia M.

Sleep Med. 2011 Sep;12(8):754-61. doi: 10.1016/j.sleep.2011.03.015. Epub 2011 Aug 6.

PMID:
21824819
10.

Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol.

Capuano A, De Corato A, Treglia M, Tringali G, Navarra P.

Pharmacol Biochem Behav. 2011 Jan;97(3):544-50. doi: 10.1016/j.pbb.2010.11.002. Epub 2010 Nov 10.

PMID:
21073890
11.

Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception.

Capuano A, De Corato A, Treglia M, Tringali G, CurrĂ² D, Dello Russo C, Navarra P.

Neuropharmacology. 2010 Mar-Apr;58(4-5):784-92. doi: 10.1016/j.neuropharm.2009.12.012. Epub 2009 Dec 29.

PMID:
20036676
12.

Measurement of non-restorative sleep in insomnia: A review of the literature.

Vernon MK, Dugar A, Revicki D, Treglia M, Buysse D.

Sleep Med Rev. 2010 Jun;14(3):205-12. doi: 10.1016/j.smrv.2009.10.002. Epub 2009 Dec 16. Review.

PMID:
20018533
13.

Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study.

Capuano A, De Corato A, Treglia M, Tringali G, Dello Russo C, Navarra P.

Eur J Pharmacol. 2009 Mar 1;605(1-3):57-62. doi: 10.1016/j.ejphar.2008.12.029. Epub 2009 Jan 10.

PMID:
19168053
14.

What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia.

Banerjee S, Samsi K, Petrie CD, Alvir J, Treglia M, Schwam EM, del Valle M.

Int J Geriatr Psychiatry. 2009 Jan;24(1):15-24. doi: 10.1002/gps.2090. Review.

PMID:
18727132
15.

Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO).

Chisholm D, Diehr P, Knapp M, Patrick D, Treglia M, Simon G; LIDO Group.

Br J Psychiatry. 2003 Aug;183:121-31.

16.

Course of depression, health services costs, and work productivity in an international primary care study.

Simon GE, Chisholm D, Treglia M, Bushnell D; LIDO Group.

Gen Hosp Psychiatry. 2002 Sep-Oct;24(5):328-35.

PMID:
12220799
17.

Long-term costs of treatment for depression: impact of drug selection and guideline adherence.

Crown WH, Treglia M, Meneades L, White A.

Value Health. 2001 Jul-Aug;4(4):295-307.

18.

Determinants of antidepressant treatment outcome.

Sood N, Treglia M, Obenchain RL, Dulisse B, Melfi CA, Croghan TW.

Am J Manag Care. 2000 Dec;6(12):1327-36.

19.

Fluoxetine and dothiepin therapy in primary care and health resource utilization: Evidence from the United Kingdom.

Treglia M, Neslusan CA, Dunn RL.

Int J Psychiatry Clin Pract. 1999;3(1):23-30. doi: 10.3109/13651509909024755.

PMID:
24945063

Supplemental Content

Loading ...
Support Center